Rhumbline Advisers Stereotaxis, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 42,949 shares of STXS stock, worth $97,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,949
Previous 48,251
10.99%
Holding current value
$97,064
Previous $87,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding STXS
# of Institutions
89Shares Held
41.1MCall Options Held
139KPut Options Held
20.6K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.9 Million7.17% of portfolio
-
Lagoda Investment Management, L.P. New York, NY3.83MShares$8.66 Million4.5% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$8.01 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$6.99 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.79MShares$6.31 Million6.12% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $169M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...